Circulating Tumor DNA May Identify Treatment Response in Colon Cancer

A new research study led by scientists at the Johns Hopkins Kimmel Cancer Center and WEHI demonstrates that circulating tumor DNA (ctDNA) can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery.